Latest Strategy News

Page 263 of 1379
Mesoblast Limited (ASX:MSB, Nasdaq:MESO) has received FDA Investigational New Drug clearance to initiate a pivotal clinical trial of its cell therapy Ryoncil in children with Duchenne Muscular Dystrophy, aiming to address inflammation-driven disease progression.
Ada Torres
Ada Torres
8 Apr 2026
Tamboran Resources Corporation has initiated an underwritten public offering of nearly 3 million shares to support expanded drilling and resource delineation in the Beetaloo Basin, alongside a concurrent institutional entitlement offer.
Maxwell Dee
Maxwell Dee
8 Apr 2026
TZ Limited (ASX:TZL) has secured $0.81 million through a private placement at a 22% premium to the last traded price, issuing 16.2 million shares with attaching options pending shareholder approval. The funds will support debt repayment, vendor payments, working capital, and growth initiatives in smart locking and data centre security.
Sophie Babbage
Sophie Babbage
8 Apr 2026
Resolution Minerals Ltd has secured FAST-41 status for its Antimony Ridge project in Idaho, a designation expected to accelerate permitting and development of this critical minerals asset. The move supports the company's integrated U.S. strategy for antimony, tungsten, and gold, enhancing investor visibility and strategic engagement.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Greenwing Resources has initiated a scoping study at its 100%-owned San Jorge Lithium Brine Project in Argentina, appointing lithium brine specialist Zelandez to lead the work. The study aims to define development pathways and an economic framework for the project, which hosts a maiden Mineral Resource Estimate of 1.07Mt LCE.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Rent.com.au Limited has clarified the timing and materiality of its recent Senior Debt Facility increase and extension, responding to an ASX query. The company also addressed insider trading compliance related to director share purchases in March 2026.
Sophie Babbage
Sophie Babbage
8 Apr 2026
Neuren Pharmaceuticals’ partner Acadia Pharmaceuticals has broadened availability of DAYBUE STIX, a new FDA-approved powder formulation of trofinetide for Rett syndrome, in the US. Early caregiver feedback and expert consensus highlight its potential role in personalised patient care.
Ada Torres
Ada Torres
8 Apr 2026
Strata Minerals Limited has expanded its Zelica Gold Project corridor to approximately 9.5km through a strategic tenement acquisition and completed a 2,209m Phase 2 RC drilling program, with assay results expected within 4-6 weeks.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Argent Minerals (ASX: ARD) has announced Managing Director Pedro Kastellorizos will step down in mid-June, with a leadership transition underway. The company remains focused on advancing its Kempfield Silver Project and exploration activities.
Maxwell Dee
Maxwell Dee
8 Apr 2026
InFocus Group Holdings Limited (ASX: IFG) has unveiled a global technical preview of Codexa, its proprietary sweepstakes casino platform, marking a key step towards commercial operations in the US market. The platform features advanced technology including blockchain fairness verification and AI-driven personalisation.
Sophie Babbage
Sophie Babbage
8 Apr 2026
Torque Metals Limited (ASX: TOR) reports significant new high-grade gold intercepts from recent drilling at its Paris Gold Project in Western Australia, extending mineralisation up to 500 metres beyond the current Mineral Resource Estimate. The company plans an interim resource update in Q2 2026 amid ongoing multi-rig drilling.
Maxwell Dee
Maxwell Dee
8 Apr 2026
Grand Gulf Energy is intensifying technical evaluations and exploration activities at its Red Helium Project in Utah following a sharp rise in global helium prices triggered by geopolitical disruptions affecting Qatar's helium exports.
Maxwell Dee
Maxwell Dee
8 Apr 2026